Filing Flows › ANI Pharmaceuticals (ANIP) › Q3 2026
ANI Pharmaceuticals (ANIP) Q3 2026 earnings results (third quarter 2026)
10-Q filed Nov 5, 2026
ANI Pharmaceuticals (ANIP) reported revenue of $291M for the third quarter 2026 (Q3 2026), +28% from a year earlier and +9% from the quarter before. Operating margin was 18.0%, net earnings $35.1M (12.1% of revenue).
ANI Pharmaceuticals, Q3 2026: revenue $291M (+28% year over year), operating margin 18.0%, net earnings $35.1M, operating cash flow $83.8M. The chart follows the revenue to costs, profit and cash.
| Q3 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $291M | +9% | +28% |
| Operating profit | $52.4M | +29% | +45% |
| Net earnings | $35.1M | +42% | +32% |
| Operating cash flow | $83.8M | +48% | +90% |
| Free cash flow | $70.3M | +31% | +85% |
What changed
Revenue was $290.8M in Q3 2026, up 28% year over year and up 9% from the previous quarter. Cortrophin Gel was the largest line at 48% of revenue. Cortrophin Gel added $36.8M year over year (up 36%), 58% of the total change. Other generic revenues declined 8%.
Operating profit was $52.4M, a 18.0% margin (up 2.1 points year over year). Of the extra revenue versus Q3 2025, 26% reached operating profit, above the 16% margin then. Total costs grew 24% against revenue growth of 28%. The fastest-growing cost line was Other operating costs (+106%). Net earnings were $35.1M, up 32% year over year. The effective tax rate was 28.3%.
Operating cash flow was $83.8M (up 90% year over year), 238% of net earnings. Non-cash charges added back $19.6M of depreciation and amortization and $11.6M of share-based compensation. Working capital and other items added $17.5M. Capital expenditures of $13.5M left free cash flow of $70.3M.
Questions
What was ANI Pharmaceuticals' revenue in the third quarter 2026?
ANI Pharmaceuticals (ANIP) reported revenue of $291M for the third quarter 2026 (Q3 2026), +28% from a year earlier and +9% from the quarter before.
Was ANI Pharmaceuticals profitable in the third quarter 2026?
Operating profit was $52.4M (18.0% of revenue) and net earnings $35.1M.